PACIRA BIOSCIENCES INC (PCRX)
US6951271005 - Common Stock
ChartMill assigns a Buy % Consensus number of 72% to PCRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 20.11. This target is 15.7% above the current price.
PCRX was analyzed by 15 analysts. The buy percentage consensus is at 72. So analysts seem to be have mildly positive about PCRX.
In the previous month the buy percentage consensus was at a similar level.
PCRX was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-12 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-11-08 | Needham | Reiterate | Buy -> Buy |
| 2024-11-07 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-10-04 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-09-24 | Jefferies | Maintains | Buy -> Buy |
| 2024-08-13 | Truist Securities | Downgrade | Buy -> Sell |
| 2024-08-12 | Needham | Maintains | Buy -> Buy |
| 2024-08-12 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2024-08-12 | JP Morgan | Downgrade | Overweight -> Underweight |
| 2024-08-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-07-31 | Needham | Reiterate | Buy -> Buy |
| 2024-07-31 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-07-31 | Raymond James | Maintains | Outperform -> Outperform |
| 2024-07-25 | Truist Securities | Maintains | Buy -> Buy |
| 2024-07-03 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2024-07-03 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-07-02 | Needham | Reiterate | Buy -> Buy |
| 2024-07-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-08 | Needham | Maintains | Buy -> Buy |
| 2024-05-08 | Barclays | Maintains | Overweight -> Overweight |
| 2024-05-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-09 | Needham | Reiterate | Buy -> Buy |
| 2024-03-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-01 | Needham | Reiterate | Buy -> Buy |
| 2024-03-01 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-02-08 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-12-20 | Raymond James | Initiate | Outperform |
| 2023-11-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-03 | Needham | Maintains | Buy -> Buy |
| 2023-11-03 | RBC Capital | Maintains | Outperform -> Outperform |